Cardiology heart disease
NicOx S.A. (Eurolist: NICOX) today announced that it has successfully completed subject enrolment in the ambulatory blood pressure monitoring (ABPM) trial for naproxcinod (HCT 3012). The randomization of 120 volunteer subjects with stable essential hypertension at 16 clinical centers in the United States was initiated in May this year and has been completed ahead of schedule. [click link for full
CHD, Heart Failure and Depression
By Newson, Louise JOURNALS WATCH
High blood pressure induces low fat metabolism in heart muscle
Aug. 3, 2006 — “The heart is the single most energy-consuming organ per weight in the body,” says Lisa de las Fuentes, M.D.
Man dies of heart attack at Sherwood Island park
A 78-year-old man who suffered a heart attack was found unresponsive in the water Sunday at Sherwood Island State Park in Westport and pronounced dead at Norwalk Hospital, authorities said.
NicOx Completes Enrolment Ahead of Schedule in ABPM Trial for Naproxcinod in Hypertensive Subjects
NicOx S.A. today announced that it has successfully completed subject enrolment in the ambulatory blood pressure monitoring trial for naproxcinod . The randomization of 120 volunteer subjects with stable essential hypertension at 16 clinical centers in the United States was initiated in May this year and has been completed ahead of schedule.
Tags: Heart Disease
